| Application no. and date | 11838957.6 (espacenet) (Federated) (European Patent Register), 20111107 | | Patent/reg. no. and date | DK/EP 2635282, 20220928 | | Publication date | 20130911 | | Priority no. and date | US 410924 P, 20101107 | | EP pub. no. and date |
EP 2635282 20130911 | | Effective date | | | Applicant/owner | Impact Biomedicines, Inc., 86 Morris Avenue
Summit, New Jersey 07901, US | | Applicant ref. no. | P80821DK01 | | Inventor | TEFFERI, Ayalew, Hematology Mayo Clinic
200 First Street S.W.
Rochester, MN 55905, US,
JAYAN, Arvind, 7509 Draper Avenue Apt. 303
La Jolla
CA 92037, US,
CACACE, Janice, 527 NE 57th Street
Miami
FL 33137, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 9/48 (2006.01) , A61P 7/00 (2006.01) | | Title | SAMMENSÆTNINGER TIL BEHANDLING AF MYELOFIBROSE | | Int. application no. | US2011059643 | | Int. publication no. | WO2012061833 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
